Ginkgo Biloba is a botanical species with a history predating the dinosaurs. The herb seamlessly integrates ancient medicinal wisdom with modern nootropic science.
Recognized for its distinctive fan-shaped leaves and adaptogenic properties, Ginkgo Biloba symbolizes resilience and has been a staple in traditional Chinese medicine for over 5,000 years.
This plant is rich in bioactive compounds such as flavonoids and terpenoids, including ginkgolides and bilobalide, which contribute to its diverse neuropharmacological effects, ranging from neurotransmitter modulation to enhanced cerebral blood flow and neuroprotection.
Scientific research supports Ginkgo Biloba's efficacy as a nootropic supplement, highlighting its cognitive-enhancing properties and potential therapeutic applications in mitigating cognitive decline and neurological disorders.
Beyond cognition, Ginkgo Biloba offers additional health benefits, including cardioprotection and antioxidant effects, reinforcing its holistic impact on human well-being.
Contents
- What is Ginkgo Biloba?
- Ginkgo Biloba as a Nootropic
- Scientific Evidence on Ginkgo Biloba's Benefits
- Health Benefits Beyond Cognition
- How to Use Ginkgo Biloba
- Safety and Side Effects
A Beginner's Guide to Ginkgo Biloba as a Natural Nootropic
What is Ginkgo Biloba?
Ginkgo biloba is known as the maidenhair tree which is celebrated as the oldest living tree species. Originating in the Permian period, approximately 286 to 248 million years ago, it is the sole survivor of the Ginkgoaceae family, which once flourished globally.
The species' remarkable survival is due to its exceptional adaptability and resistance to disease, alongside the preservation efforts of Buddhist monks who cultivated these trees within their temple grounds.
Renowned for its medicinal properties and historical significance, Ginkgo biloba is extensively studied and utilized in modern herbal supplementation.
The leaves and seeds are harvested for their health-promoting bioactive compounds, which have been the subject of extensive research. These compounds are explored for their potential in enhancing cognitive function, supporting neurogenesis, and providing neuroprotective effects against various neurological conditions.
Chemical Composition
The chemical composition of Ginkgo biloba includes a rich array of bioactive compounds, primarily found in its seeds and leaves, that contribute to its wide range of medicinal benefits.
These active constituents include minerals, flavonoids, triterpene lactones, phenolic compounds, ginkgotoxin (4-O-methylpyridoxine), ginkgolic acid, and ginnol, which are known to inhibit the growth of fungi and bacteria.
Among these, flavone glycosides, biflavones, triterpene lactones such as ginkgolides A, B, C, J, M, and bilobalide, alkylphenols, proanthocyanidins, polyprenols, phenolic acids, 6-hydroxykynurenic acid, and ginkgotoxin are predominantly found in the leaves.
Ginkgolides, unique to Ginkgo biloba, are a set of trilactonic diterpenes (ginkgolides A, B, and C), contributing to the plant's potent anti-inflammatory, neuroprotective, and circulatory benefits.
These compounds have been specifically shown to act as platelet-activating factor (PAF) antagonists, thereby inhibiting platelet aggregation and enhancing blood flow.
Flavonoids in Ginkgo biloba, including quercetin, kaempferol, and isorhamnetins, are major antioxidants that play a critical role in scavenging free radicals and acting as heavy metal chelators due to their phenolic structures.
These flavonoids, along with proanthocyanidins and various organic acids such as glucose, rhamnose, hydroxykynurenic, kynurenic, protocatechuic, vanillic, and shikimic acids, form the pharmacologically active base of Ginkgo biloba extracts.
Historical Context and Traditional Uses
Characterized by its unique, fan-shaped leaves that turn a vibrant yellow in autumn, Ginkgo biloba is both a symbol of beauty and a repository of ancient genetic heritage.
The Ginkgo tree, with its distinctive foliage, not only captivates the eye but also holds a revered place in traditional Chinese medicine. For nearly 5000 years, it has been utilized for a variety of health concerns, most notably asthma.
Ginkgo biloba's resilience is not just limited to its biological and health-related attributes.
The tree has an extraordinary ability to resist disease, pollution, and environmental stress, which has allowed it to survive through epochs and become a celebrated ornamental species around the world. Its nuts are considered a delicacy in many cultures, while the leaves are used in traditional medicine to treat various ailments, from cognitive disorders to cardiovascular issues.
In modern times, Ginkgo biloba has found its way into the heart of alternative medicine, particularly as a dietary supplement aimed at improving memory and concentration, reducing symptoms related to dementia, and enhancing overall mental clarity and well-being.
The standardized extract of Ginkgo biloba leaves, known as EGb 761, has been the subject of numerous scientific studies exploring its efficacy in treating and managing a wide range of health issues, from cognitive impairments and dementia to peripheral vascular diseases and neurosensory problems.
Ginkgo Biloba as a Nootropic
Understanding Nootropics
Nootropics, often referred to as "smart drugs" or cognitive enhancers, are substances that improve cognitive function, particularly executive functions, memory, creativity, or motivation, in healthy individuals. The term "nootropic" was coined in the 1970s by Romanian psychologist and chemist Dr. Corneliu E. Giurgea, who defined nootropics as compounds that enhance learning and memory, protect the brain against physical or chemical injuries, and possess few or no side effects.
Nootropics can be broadly categorized into two groups: natural and synthetic. Natural nootropics, such as Ginkgo biloba, Bacopa monnieri, and Rhodiola rosea, are derived from plants and have been used in traditional medicine for centuries. Synthetic nootropics, such as Piracetam and Modafinil, are man-made compounds developed to enhance cognitive function and are often used in clinical settings to treat various neurological conditions.
The primary benefits of nootropics include enhanced memory, improved focus and attention, increased mental energy, and better mood. These effects are achieved through various mechanisms, such as increasing the availability of neurotransmitters, improving cerebral blood flow, and providing neuroprotection.
Cognitive Decline
Cognitive decline is a major concern for aging populations, and researchers are exploring various ways to slow it down. One promising option is Ginkgo biloba extract (GBE). Numerous studies have looked into how effective GBE is in slowing cognitive decline, especially in elderly individuals who do not have dementia.
One notable study by Amieva et al. (2013) tracked the long-term effects of GBE on brain function. This study, part of the PAQUID project, followed 3,612 people aged 65 and older for 20 years. The participants were divided into three groups: 589 people who used GBE (EGb761H), 149 who used another drug called piracetam, and 2,874 who used neither.
The researchers measured cognitive decline using several tests, including the Mini-Mental State Examination (MMSE), verbal fluency tests, and the Benton Visual Retention Test (BVRT). They used a detailed statistical model to analyze the data.
The study found that those who took GBE had significantly slower cognitive decline compared to those who did not take it. Specifically, the GBE group had a slower decrease in their MMSE scores, with an average difference of 0.5 points per follow-up visit over 20 years. By the end of the study, the GBE group had a five-point advantage in MMSE scores compared to the control group. On the other hand, the group taking piracetam experienced faster cognitive decline than both the GBE group and the control group.
When it came to verbal fluency and visual memory, the GBE group did not show significant differences compared to the control group, while the piracetam group showed a greater decline. This suggests that GBE specifically benefits overall cognitive function rather than specific areas of cognition.
The protective effects of GBE come from its various actions. It acts as an antioxidant, reduces inflammation, and prevents cell death. GBE also helps reduce the buildup of harmful amyloid-beta proteins, protects energy-producing parts of cells (mitochondria), improves neurotransmission, and boosts blood flow and microcirculation in the brain. All these effects together help preserve cognitive functions in older adults.
Additionally, GBE's role in reducing the need for psychotropic drugs, like antidepressants and antipsychotics, supports its benefits for cognitive health. The study found that people using GBE were less likely to need these medications, which can negatively impact cognitive function.
Neurogenesis
Neurogenesis, the creation of new neurons in the brain, is essential for maintaining cognitive functions and overall brain health. This process is severely disrupted in neurodegenerative diseases like Alzheimer’s disease (AD). Recent research has shown that Ginkgo biloba extract (EGb 761) may enhance neurogenesis and reduce cognitive decline linked to such diseases.
A key study by Ge et al. (2021) investigated how different doses of EGb 761 affect neurogenesis and memory in a mouse model of AD. The study involved daily injections of EGb 761 at doses of 0, 10, 20, and 30 mg/kg over four months. Researchers examined the effects on learning and memory, amyloid-beta (Aβ) pathology, and neurogenesis in the hippocampus, a brain region crucial for memory.
The findings revealed that doses of 20 and 30 mg/kg of EGb 761 significantly improved memory in the AD mice. Tests like the Morris Water Maze and novel object recognition showed that treated mice had better spatial memory and recognition abilities compared to untreated mice.
Additionally, the study found that EGb 761 reduced the number of Aβ positive signals in the hippocampus, which are indicators of AD pathology. The treatment also boosted the number of new neurons and enhanced the complexity and connectivity of neurons in the hippocampus. Specifically, there were more BrdU-positive cells, which mark new neuron formation, in the EGb 761 treated mice than in the untreated ones. This suggests that EGb 761 promotes the growth of new neurons, contributing to better cognitive functions.
Cognitive Impairment
Cognitive impairment and dementia, including Alzheimer's disease (AD) and vascular dementia (VaD), are serious health issues affecting millions of people worldwide. Researchers are looking into Ginkgo biloba, a traditional herbal remedy, to help manage these conditions.
A large analysis by Hashiguchi et al. (2015) reviewed 13 studies involving 2,381 patients. It found that Ginkgo biloba extract (EGb761) significantly improved cognitive function. Patients taking a daily dose of 240 mg showed substantial improvements in their cognitive scores, specifically in the Syndrome Kurztest (SKT), a test for cognitive abilities. The improvement was measured as a standard mean difference (SMD) of -0.71, indicating a strong benefit, especially for those with AD and VaD.
Ginkgo biloba is also safe to use. The analysis showed fewer patients stopped taking it due to side effects compared to those taking a placebo (dummy treatment). The odds ratio was 1.72, meaning those on Ginkgo biloba were less likely to drop out. Common side effects like headaches and dizziness were rare and similar to those in the placebo group. This suggests Ginkgo biloba is both effective and safe, particularly at the 240 mg daily dose, for improving cognitive function in affected individuals.
Another review by Tan et al. (2015) looked at nine trials with 2,561 patients. It confirmed that standardized Ginkgo biloba extract (EGb761) improved cognitive function, daily living activities, and overall clinical outcomes compared to placebo. The improvement in cognitive scores was particularly significant at a daily dose of 240 mg, with a weighted mean difference (WMD) of -2.86.
Moreover, EGb761 was especially beneficial for patients with neuropsychiatric symptoms (NPS), such as mood disturbances. These patients showed greater improvements in daily activities and cognitive function, with a WMD of -3.95 for ADAS-cog scores, another cognitive test. Safety data indicated no major concerns, with minor side effects like dizziness and headaches occurring less frequently in the EGb761 group compared to placebo.
Scientific Evidence on Ginkgo Biloba's Benefits
Neurological Disorders
Neurological disorders include a variety of conditions affecting the nervous system, such as Alzheimer's disease (AD), vascular dementia (VaD), and behavioral and psychological symptoms of dementia (BPSD). Recent clinical guidelines and studies have shown that Ginkgo biloba extract (EGb 761®) may help manage these conditions. Clinical trials have found that EGb 761® can improve cognitive function in patients with mild to moderate dementia.
One key study by Le Bars and colleagues involved 236 patients with uncomplicated dementia who took 120 mg/day of EGb 761® for a year. They used two main tests to measure results: the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) and the Geriatric Evaluation by Relative’s Rating Instrument (GERRI). The study found significant improvements in both tests, showing that EGb 761® helped improve cognitive function in these patients (Le Bars et al., 1997).
Another study tested 156 dementia patients who took 240 mg/day of EGb 761® for 24 weeks. Results were measured using the Syndrom Kurz Test (SKT), Clinical Global Impressions (CGI), and Nüberger Alters-Beobachtungsskala (NAB). This study also found significant improvements, indicating EGb 761®'s effectiveness in boosting cognitive performance in dementia patients (Kanowski et al., 1997).
In a study with 395 outpatients with AD or VaD, patients took 240 mg/day of EGb 761® for 22 weeks. Researchers used the Neuropsychiatric Inventory (NPI), SKT, and activities-of-daily-living subscale of Gottfries–Bråne–Steen (GBS-ADL) to measure results. Significant improvements were seen in all tests, confirming the positive effects of EGb 761® on cognitive function and daily activities (Napryeyenko et al., 2007).
Ihl and colleagues studied 327 outpatients taking 240 mg/day of EGb 761® for 24 weeks. They used several tests, including SKT, NPI, and Verbal Fluency Test, and found significant improvements, supporting EGb 761®'s efficacy in treating dementia with neuropsychiatric symptoms (Ihl et al., 2011).
In another 24-week trial with 402 elderly patients, EGb 761® was given at a dose of 240 mg/day. Cognitive function was assessed using SKT, NPI, and ADCS-CGIC, and significant improvements were observed in all areas, further validating the cognitive benefits of EGb 761® in elderly dementia patients (Herrschaft et al., 2012).
These studies suggest that taking 240 mg/day of EGb 761® for more than 24 weeks can significantly improve cognitive function in patients with mild to moderate AD or VaD. The clinical evidence supports the use of EGb 761® as a treatment option for managing cognitive decline in neurological disorders (Liu et al., 2020).
Blood Flow and Circulation
A pilot study by Mashayekh et al. (2011) looked at how Ginkgo biloba extract (EGb 761®) affects blood flow in the brain. The study involved nine healthy men, around 61 years old, who took 60 mg of EGb 761® twice a day for four weeks. Using advanced brain imaging techniques, the researchers found a slight increase in blood flow in a specific brain region and a significant overall increase of 15% in white matter and 13% in gray matter. This suggests that EGb 761® can boost blood flow to the brain, potentially helping conditions that affect brain circulation.
Boelsma et al. (2004) conducted a study to see how EGb 761® impacts blood flow in the skin. The study involved 27 healthy middle-aged people who took 240 mg of EGb 761® or a placebo for three weeks. Using laser technology to measure skin blood flow, they found that while the average skin blood flow decreased with EGb 761®, the changes were related to initial blood flow levels. This means that EGb 761® helps regulate blood flow, which could be useful for conditions needing stable blood flow.
Wu et al. (2007) studied the effects of EGb 761® on blood flow in the heart for patients with coronary artery disease (CAD). In this trial, 80 patients received either EGb 761® or a saline solution. Using ultrasound, the researchers measured blood flow in a major heart artery and the brachial artery. They found significant increases in heart artery blood flow and improved artery dilation in the EGb 761® group compared to the control group. Specifically, the peak blood flow velocities increased by 16.14% and 9.14%, and overall blood flow improved by 15.23%. Additionally, artery dilation improved by 69.75%. These results indicate that EGb 761® enhances heart blood flow and artery flexibility, which may benefit heart health and reduce the risk of heart problems.
Neurotransmitter Release
A study by Yoshitake et al. (2010) looked at how Ginkgo biloba extract (EGb 761®) affects key brain chemicals like dopamine, noradrenaline, and serotonin. Researchers gave rats 100 mg of EGb 761® per kilogram of body weight each day for 14 days. They found that this treatment significantly boosted levels of dopamine and noradrenaline in the prefrontal cortex, a part of the brain important for thinking and decision-making. Serotonin levels, however, were not affected. The increase in dopamine was mainly due to specific components in EGb 761® called flavonoids and ginkgolides. This suggests that EGb 761® might improve cognitive functions by raising dopamine levels in the brain.
Kehr et al. (2012) studied the effect of EGb 761® on dopamine and acetylcholine levels in another brain region called the medial prefrontal cortex. Rats received either 100 or 300 mg of EGb 761® per kilogram of body weight daily for 14 days. The researchers found that this repeated treatment significantly increased dopamine levels and also moderately boosted noradrenaline levels, without changing serotonin levels. They pinpointed that specific flavonol glycosides in the extract, particularly compounds named Q-ag and K-ag, were responsible for the rise in dopamine and acetylcholine. This indicates that these specific components of EGb 761® are crucial for improving cognitive functions by increasing both dopamine and acetylcholine levels.
Fehske et al. (2009) explored how EGb 761® influences the uptake of neurotransmitters in the brain. Mice were given 100 mg of EGb 761® per kilogram of body weight daily for 14 days. The study showed that EGb 761® significantly reduced the uptake of norepinephrine in the brain, which means more of this neurotransmitter remained available. However, it did not affect serotonin uptake or the activity of an enzyme that breaks down neurotransmitters (monoamine oxidase). Since dopamine clearance in the brain's frontal cortex relies on norepinephrine transporters, this reduction in norepinephrine uptake helps explain the increased dopamine levels found in earlier studies. This mechanism likely contributes to EGb 761®'s positive effects on cognition and attention.
Health Benefits Beyond Cognition
Antioxidant
The main active ingredients in Ginkgo biloba that make it effective are flavonoids and terpenoids. These substances help by neutralizing harmful free radicals and binding to metal ions that can promote oxidation (Singh et al., 2019).
Ginkgo biloba extract (GBE) works as an antioxidant by reducing oxidative stress, which is linked to diseases like Alzheimer's. The flavonoids in GBE, including quercetin and myricetin, are crucial for neutralizing harmful reactive oxygen species (ROS) and boosting the activity of antioxidant enzymes like superoxide dismutase (SOD) and glutathione (GSH) reductase (Singh et al., 2019).
Lab studies have shown that GBE can significantly reduce oxidative damage caused by hydrogen peroxide in brain cells (Ni et al., 1996; Oyama et al., 1996). In animal studies, GBE increased the activity of antioxidants like SOD and catalase, suggesting it strengthens the body's own antioxidant defenses (Bridi et al., 2001; Colak et al., 1998).
GBE protects the brain through several mechanisms. It reduces oxidative stress by directly neutralizing ROS and by increasing the production of antioxidant molecules. Studies on models that mimic Alzheimer’s, like certain worms and cell lines, have shown that GBE lowers both normal and increased levels of ROS (Wu et al., 2006; Smith and Luo, 2004). Additionally, GBE improves mitochondrial function, helping maintain cell energy and reducing oxidative damage (Rhein et al., 2010).
The flavonoids in GBE are also effective at binding to iron. This is important because iron can lead to the creation of highly reactive hydroxyl radicals. This binding ability helps prevent the formation of amyloid-beta fibrils, which are associated with Alzheimer’s disease (Smith et al., 2003; Ramassamy, 2006).
Anti-Inflammatory
The anti-inflammatory effects of Ginkgo biloba extract (GBE) are mainly due to its ability to control important inflammation pathways and lower the levels of substances that cause inflammation. GBE contains flavonoids and terpenoids, which are powerful anti-inflammatory agents. These substances stop the NF-κB pathway, a major player in inflammation, from being activated. This results in lower levels of inflammatory substances like TNF-α, IL-1β, and IL-6 (Kaur et al., 2018).
Kaur et al. (2018) studied how GBE protects against brain damage in rats caused by a toxin called trimethyltin (TMT). They found that GBE significantly improved brain function and reduced markers of oxidative stress, such as MDA and ROS. Additionally, GBE reduced the activation of brain cells and inflammatory markers elevated by TMT. The study showed noticeable improvement in brain cell damage, highlighting GBE's anti-inflammatory and antioxidant properties.
Another study by Kotakadi et al. (2008) found that GBE (EGb 761) helps reduce colitis (inflammation of the colon) in mice. It did this by causing the death of certain T cells that promote inflammation. EGb 761 also reduced the activation of macrophages and lowered inflammation markers like iNOS, Cox-2, and TNF-α. This supports using GBE to help manage colitis and potentially lower the risk of related colon cancer.
Zhu et al. (2019) looked at GBE's anti-inflammatory properties in lung diseases. They found that biflavones in the extract were the main anti-inflammatory agents. These biflavones significantly reduced inflammation markers and activity in lung cells and an allergic mouse model. This suggests that GBE can be a useful treatment for airway inflammation.
Zhang et al. (2022) examined the effects of GBE on heart and brain inflammation in rats on a high-fat diet and under chronic stress. Over 13 weeks, GBE significantly reduced inflammation in the heart and oxidative stress in the brain. The protective effects were linked to the inhibition of the NF-κB pathway, reducing inflammation markers in heart and brain tissues. GBE also improved overall immunity and increased anti-inflammatory cytokines like IL-37 and IL-38, showing its broad anti-inflammatory potential.
Anti-Aging
Aging is a natural process that affects our bodies and minds in various ways. However, there are ways to help reduce some of the negative effects of aging. One promising approach involves using herbal remedies like Ginkgo biloba (GB). This section looks at how Ginkgo biloba can improve the overall well-being of older adults, based on findings from multiple studies.
Researchers have conducted several studies to see if Ginkgo biloba can help improve cognitive functions (like memory and thinking skills) and overall well-being in older people. The main goal was to find out if GB could be a useful addition to treatments for age-related issues like Alzheimer's disease, heart disease, and metabolic disorders.
The research methods included different types of studies, such as randomized controlled trials (RCTs), systematic reviews, and meta-analyses. For example, a review by Barbalho et al. (2022) looked at results from 14 clinical trials where GB was given to elderly participants. These studies often compared GB with a placebo to see if it improved memory, thinking skills, and quality of life.
The results showed that Ginkgo biloba could improve various cognitive functions, including memory, decision-making, attention, and mood. In clinical trials, people with mild cognitive impairment and Alzheimer's disease saw significant improvements in memory and overall thinking skills after taking GB. These benefits are thought to come from GB's antioxidant, anti-inflammatory, and brain-protective properties, which help reduce damage from oxidative stress and improve blood flow in the brain.
Ginkgo biloba also helps cardiovascular health by improving blood circulation and slowing down the development of artery-clogging plaques. Studies have shown that GB can lower blood pressure, reduce fasting blood sugar levels, and decrease markers of oxidative stress and inflammation, all of which are important for maintaining heart health in older adults.
Additionally, Ginkgo biloba has shown potential benefits for metabolic health. It can help manage insulin resistance, lower body mass index (BMI), and reduce waist size. The active compounds in GB, such as flavonoids and terpenoids, play a key role in improving metabolic functions and overall health.
How to Use Ginkgo Biloba
This ancient remedy, derived from the leaves of the Ginkgo Biloba tree, has been scientifically supported to offer a wide range of therapeutic effects, making it a valuable supplement for overall wellness.
Below are various ways to incorporate Ginkgo Biloba into your daily regimen, ensuring you reap its maximum benefits.
Different Forms of Ginkgo Biloba
- Extracts: Ginkgo Biloba is most commonly available in the form of standardized extracts. These extracts ensure a consistent dose of the active ingredients, flavonoids, and terpenoids, which are responsible for its medicinal properties. The extracts can be taken in capsule or tablet form, offering convenience and precision in dosage.
- Teas: For those who prefer a more traditional approach, Ginkgo Biloba leaves can be brewed into a herbal tea. This method allows for a soothing and enjoyable way to consume Ginkgo, although the concentration of active compounds may vary compared to standardized extracts.
- Tinctures: Liquid tinctures of Ginkgo Biloba provide a versatile option, allowing for dose customization and ease of use. Tinctures can be added to water, juice, or any other beverage, making them a convenient choice for daily supplementation.
Recommended Dosages
The efficacy of Ginkgo Biloba largely depends on the correct dosage.
For cognitive enhancement and to improve blood circulation, the recommended dosage typically ranges from 120 mg to 240 mg per day, divided into two or three doses.
It is essential to start with a lower dose to assess tolerance before gradually increasing to the desired amount.
Timing and Combining with Other Supplements
- Timing: Ginkgo Biloba can be taken at any time of the day, though some prefer taking it in the morning to take advantage of its circulatory benefits throughout the day. If you find Ginkgo to be stimulating, morning administration may prevent any potential interference with sleep.
- Combining with Other Supplements: Ginkgo Biloba can be combined with other nootropics or supplements to enhance overall cognitive function and health benefits. For instance, pairing Ginkgo with Panax Ginseng can amplify cognitive benefits due to their complementary effects on enhancing memory and improving blood flow. However, it's crucial to consult with a healthcare professional before starting any new supplement regimen, especially when combining multiple products, to avoid potential interactions.
Incorporating Ginkgo Biloba into your daily routine offers a natural way to support cognitive health, circulation, and overall well-being.
By choosing the form that best suits your lifestyle and following the recommended dosages, you can safely enjoy the wide-ranging benefits of this ancient nootropic.
Safety and Side Effects
General Safety of Ginkgo Biloba
Ginkgo Biloba, derived from the leaves of the Ginkgo tree, is considered relatively safe for most people when consumed in moderate amounts.
The consumption of Ginkgo leaf products is generally associated with a low risk of adverse effects.
This herbal supplement has been part of dietary practices for centuries, particularly in Chinese and Japanese cuisines, where Ginkgo nuts are consumed as part of the diet.
Potential Side Effects and Contraindications
While Ginkgo Biloba is generally well-tolerated, excessive consumption can lead to certain adverse effects.
These include gastrointestinal disturbances, headaches, dizziness, excessive bleeding, allergic skin reactions, and, on rare occasions, anaphylaxis-like reactions, particularly with intravenous administration.
A specific case involved a woman experiencing vomiting and clonic convulsions after consuming a large amount of Ginkgo nuts, attributed to 4’-Methoxypyridoxine, a compound in the nuts that may induce convulsions by affecting brain GABA levels.
Ginkgo Biloba's effect on blood clotting, due to its inhibitory action on platelet-activating factor (PAF), suggests caution in individuals prone to bleeding disorders. While standard dosages (120 to 240 mg/day) do not significantly affect PAF, higher doses have been reported to cause hemorrhage in both animal studies and humans.
Interactions with Medications and Specific Health Conditions
Ginkgo Biloba may interact with several medications, including anticoagulants, antidepressants, antiepileptics, antidiabetics, diuretics, nonsteroidal anti-inflammatory drugs, and other herbal drugs.
These interactions are mainly attributed to the flavonoid and terpenoid components of Ginkgo, which can inhibit specific enzymes, including those in the cytochrome P450 family.
However, the extent of these interactions and their clinical significance can vary, with some studies reporting no significant effects on drug metabolism or clotting status in healthy subjects.
Importance of Consulting with a Healthcare Professional
Given the potential for side effects and drug interactions, it is crucial for individuals considering Ginkgo Biloba supplementation to consult with a healthcare professional.
This is particularly important for pregnant and lactating women, as data regarding the effects on fertility, lactation, and pregnancy are insufficient to draw definitive conclusions.
Additionally, individuals with pre-existing health conditions or those taking medication should seek medical advice to ensure safe and effective use of Ginkgo Biloba.
Conclusion
Ginkgo biloba is a majestic relic from the ancient world that continues to stand tall in the realm of natural supplements.
The unique bioactive compounds within Ginkgo biloba—flavonoids and terpenoids—embody the tree's resilience and therapeutic prowess, contributing to its cognitive-enhancing and neuroprotective effects.
As we've explored, Ginkgo biloba's benefits extend far beyond cognitive enhancement, touching on cardiovascular health, stress reduction, anti-inflammatory effects, and even potential anti-aging properties.
Its versatility as a supplement, available in various forms from extracts to teas, allows for easy integration into daily life, catering to diverse preferences and health goals.
Are you considering joining the ranks of those who have experienced the cognitive benefits of nootropics? To learn more about how our Mood & Wellbeing Nootropic Supplement might fit into your lifestyle, visit us at nooroots.
Frequently Asked Questions
What is Ginkgo Biloba?
Ginkgo Biloba is a natural supplement derived from the leaves of the Ginkgo tree, known for its cognitive-enhancing properties.
How does Ginkgo Biloba work as a nootropic?
Ginkgo Biloba enhances cognitive function by improving blood flow to the brain, providing antioxidant protection, and reducing inflammation.
Can Ginkgo Biloba improve memory?
Yes, studies suggest that Ginkgo Biloba can enhance memory and cognitive performance, particularly in older adults.
Is Ginkgo Biloba safe for daily use?
Ginkgo Biloba is generally safe for daily use, but it's important to follow recommended dosages and consult with a healthcare provider, especially if taking other medications.
What are the benefits of Ginkgo Biloba for the brain?
Ginkgo Biloba supports brain health by increasing cerebral blood flow, protecting against oxidative stress, and potentially reducing symptoms of cognitive decline.
How much Ginkgo Biloba should I take for cognitive benefits?
Typical dosages for cognitive benefits range from 120 to 240 mg per day. It's best to follow specific product guidelines or consult a healthcare professional.
Are there any side effects of taking Ginkgo Biloba?
Some people may experience mild side effects such as headaches, dizziness, or gastrointestinal issues. Severe side effects are rare but possible.
Can Ginkgo Biloba help with anxiety and depression?
Yes, Ginkgo Biloba has been shown to have anxiolytic and antidepressant effects by modulating neurotransmitter activity and improving brain function.
What is the best way to take Ginkgo Biloba for nootropic effects?
Ginkgo Biloba can be taken in various forms, including capsules, tablets, and extracts. It is best absorbed when taken with food.
How long does it take to see the effects of Ginkgo Biloba on cognitive function?
The cognitive benefits of Ginkgo Biloba can typically be observed within 4 to 6 weeks of consistent use, though this may vary by individual.
Learn more about the vitamins, minerals and plant extracts we use to give your brain a daily boost
- Cacao
- Ginkgo Biloba
- Ashwagandha
- N-Acetyl L-Tyrosine
- Holy Basil
- L-Theanine
- Rhodiola Rosea
- Guarana Seed
- Piperine
References
- Xie, L., Zhu, Q. and Lu, J. (2022). Can We Use Ginkgo biloba Extract to Treat Alzheimer’s Disease? Lessons from Preclinical and Clinical Studies. Cells, 11(3), p.479. doi:https://doi.org/10.3390/cells11030479.
- Tan, M.-S., Yu, J.-T., Tan, C.-C., Wang, H.-F., Meng, X.-F., Wang, C., Jiang, T., Zhu, X.-C. and Tan, L. (2014). Efficacy and Adverse Effects of Ginkgo Biloba for Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease, [online] 43(2), pp.589–603. doi:https://doi.org/10.3233/jad-140837.
- Amieva, H., Meillon, C., Helmer, C., Barberger-Gateau, P. and Dartigues, J.F. (2013). Ginkgo Biloba Extract and Long-Term Cognitive Decline: A 20-Year Follow-Up Population-Based Study. PLoS ONE, [online] 8(1), p.e52755. doi:https://doi.org/10.1371/journal.pone.0052755.
- Ge, W., Ren, C., Xing, L., Guan, L., Zhang, C., Sun, X., Wang, G., Niu, H. and Qun, S. (2021). Ginkgo biloba extract improves cognitive function and increases neurogenesis by reducing Aβ pathology in 5×FAD mice. American Journal of Translational Research, [online] 13(3), pp.1471–1482. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014356/.
- Birks, J. and Grimley Evans, J. (2009). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews, [online] (1). doi:https://doi.org/10.1002/14651858.cd003120.pub3.
- Barbalho, S.M., Direito, R., Laurindo, L.F., Marton, L.T., Guiguer, E.L., Goulart, R. de A., Tofano, R.J., Carvalho, A.C.A., Flato, U.A.P., Capelluppi Tofano, V.A., Detregiachi, C.R.P., Bueno, P.C.S., Girio, R.S.J. and Araújo, A.C. (2022). Ginkgo biloba in the Aging Process: A Narrative Review. Antioxidants, [online] 11(3), p.525. doi:https://doi.org/10.3390/antiox11030525.
- Hashiguchi, M., Ohta, Y., Shimizu, M., Maruyama, J. and Mochizuki, M. (2015). Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia. Journal of Pharmaceutical Health Care and Sciences, [online] 1(1). doi:https://doi.org/10.1186/s40780-015-0014-7.
- Mahadevan, S. and Park, Y. (2007). Multifaceted Therapeutic Benefits of Ginkgo biloba L.: Chemistry, Efficacy, Safety, and Uses. Journal of Food Science, 73(1), pp.R14–R19. doi:https://doi.org/10.1111/j.1750-3841.2007.00597.x.
- Singh, S.K., Srivastav, S., Castellani, R.J., Plascencia-Villa, G. and Perry, G. (2019). Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, [online] 16(3), pp.666–674. doi:https://doi.org/10.1007/s13311-019-00767-8.
- Liu, H., Ye, M. and Guo, H. (2020). An Updated Review of Randomized Clinical Trials Testing the Improvement of Cognitive Function of Ginkgo biloba Extract in Healthy People and Alzheimer’s Patients. Frontiers in Pharmacology, [online] 10. doi:https://doi.org/10.3389/fphar.2019.01688.
- Le Bars, P. L., Katz, M. M., Berman, N., Itil, T. M., Freedman, A. M., and Schatzberg, A. F. (1997). A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. JAMA. 16, 1327–1332. doi: 10.1001/jama.278.16.1327
- Kanowski, S., Herrmann, W., Stephan, K., Wierich, W., and Hörr, R. (1996). Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the alzheimer type or multiinfarct dementia. Pharmacopsychiatry 2, 47 56. doi: 10.1055/s-2007-979544
- Napryeyenko, O., and Borzenko, I. (2007). Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial. Arzneimittelforschung. 1, 4–11. doi: 10.1055/s-0031-1296579
- Ihl, R., Bachinskaya, N., Korczyn, A. D., Vakhapova, V., Tribanek, M., Hoerr, R., et al. (2011). Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. Int. J. Geriatr. Psychiatry 11, 1186–1194. doi: 10.1002/gps.2662
- Herrschaft, H., Nacu, A., Likhachev, S., Sholomov, I., Hoerr, R., and Schlaefke, S. (2012). Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. J. Psychiatr. Res. 6, 716–723. doi: 10.1016/j.jpsychires.2012.03.003
- Bridi R, Crosetti FP, Steffen VM, Henriques AT. The antioxidant activity of standardized extract of Gingko biloba (EGb 761) in rats. Phytother Res 2001;15:449–451.
- Colak Ö, Sahin A, Alatas Ö, Inal M, Yasar B, Kiper H. The effect of Ginkgo biloba on the activity of catalase and lipid peroxidation in experimental strangulation ileus. Int J Clin Lab Res 1998;28: 69–71.
- Ni Y, Zhao B, Hou J, Xin W. Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals. Neurosci Lett 1996;214(2–3):115–8.
- Oyama Y, Chikahisa L, Ueha T, Kanemaru K, Noda K. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res 1996;712(2):349–52.
- Smith JV, Luo Y. Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol 2004;64:465–472
- Smith JV, Luo Y. Elevation of oxidative free radicals in Alzheimer’s disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis 2003, 5, 287–300.
- Wu Y, Wu Z, Butko P, et al. Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 2006;26:13102–13113.
- Rhein V, Giese M, Baysang G, et al. Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues Aβinduced failure. PLoS One 2010;5(8):e12359.
- Kaur, S., Sharma, N., & Nehru, B. (2017). Anti-inflammatory effects of Ginkgo biloba extract against trimethyltin-induced hippocampal neuronal injury. Inflammopharmacology, 26(1), 87–104. https://doi.org/10.1007/s10787-017-0396-2
- Kotakadi, V. S., Jin, Y., Hofseth, A. B., Ying, L., Cui, X., Volate, S., Chumanevich, A., Wood, P. A., Price, R. L., McNeal, A., Singh, U. P., Singh, N. P., Nagarkatti, M., Nagarkatti, P. S., Matesic, L. E., Auclair, K., Wargovich, M. J., & Hofseth, L. J. (2008). Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis. Carcinogenesis, 29(9), 1799–1806. https://doi.org/10.1093/carcin/bgn143
- Tao, Z., Jin, W., Ao, M., Zhai, S., Xu, H., & Yu, L. (2019). Evaluation of the anti-inflammatory properties of the active constituents in Ginkgo biloba for the treatment of pulmonary diseases. Food & Function, 10(4), 2209–2220. https://doi.org/10.1039/c8fo02506a
- Zhang, L., Li, G., Tao, S., Xia, P., Chaudhry, N., Kaura, S., Stone, S. S., & Liu, M. (2022). Ginkgo Biloba Extract Reduces Cardiac and Brain Inflammation in Rats Fed a HFD and Exposed to Chronic Mental Stress through NF-κB Inhibition. Mediators of Inflammation, 2022, 1–15. https://doi.org/10.1155/2022/2408598
- Mashayekh, A., Pham, D.L., Yousem, D.M., et al., 2011. Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study. Neuroradiology, 53(3), pp.185-191. DOI: 10.1007/s00234-010-0790-6.
- Boelsma, E., Lamers, R.J.A.N., Hendriks, H.F.J., et al., 2004. Evidence of the regulatory effect of Ginkgo biloba extract on skin blood flow and study of its effects on urinary metabolites in healthy humans. Planta Medica, 70(11), pp.1052-1057. DOI: 10.1055/s-2004-832646.
- Wu, Y., Li, S., Cui, W., et al., 2007. Ginkgo biloba extract improves coronary blood flow in patients with coronary artery disease: role of endothelium-dependent vasodilation. Planta Medica, 73(7), pp.624-628. DOI: 10.1055/s-2007-981536.
- Yoshitake, T., Yoshitake, S., Kehr, J., 2010. The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex. British Journal of Pharmacology, 159(3), pp.659-668. DOI: 10.1111/j.1476-5381.2009.00580.x.
- Kehr, J., Yoshitake, S., Ijiri, S., et al., 2012. Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®. International Psychogeriatrics, 24(Suppl 1), pp.S25-S34. DOI: 10.1017/S1041610212000567.
- Fehske, C.J., Leuner, K., Müller, W.E., 2009. Ginkgo biloba extract (EGb761) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment. Pharmacological Research, 60(1), pp.68-73. DOI: 10.1016/j.phrs.2009.02.012.